Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
or

Exact Sciences Cor (EXAS)

Exact Sciences Cor (EXAS)
36.00 x 1 46.65 x 1
Post-market by (Cboe BZX)
43.83 +1.28 (+3.01%) 04/07/25 [NASDAQ]
36.00 x 1 46.65 x 1
Post-market 46.20 +2.37 (+5.41%) 16:20 ET
Quote Overview for Mon, Apr 7th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
40.12
Day High
46.48
Open 40.74
Previous Close 42.55 42.55
Volume 5,777,900 5,777,900
Avg Vol 2,220,970 2,220,970
Stochastic %K 33.63% 33.63%
Weighted Alpha -35.61 -35.61
5-Day Change +0.54 (+1.25%) +0.54 (+1.25%)
52-Week Range 40.12 - 74.44 40.12 - 74.44
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,903,876
  • Shares Outstanding, K 185,755
  • Annual Sales, $ 2,759 M
  • Annual Income, $ -1,029 M
  • EBIT $ -179 M
  • EBITDA $ 905 M
  • 60-Month Beta 1.14
  • Price/Sales 2.98
  • Price/Cash Flow 7.86
  • Price/Book 3.41

Options Overview Details

View History
  • Implied Volatility 69.13% ( +6.05%)
  • Historical Volatility 42.40%
  • IV Percentile 96%
  • IV Rank 77.24%
  • IV High 77.02% on 07/29/24
  • IV Low 42.36% on 09/03/24
  • Put/Call Vol Ratio 0.92
  • Today's Volume 732
  • Volume Avg (30-Day) 953
  • Put/Call OI Ratio 0.69
  • Today's Open Interest 43,607
  • Open Int (30-Day) 42,351

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 24 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.35
  • Number of Estimates 5
  • High Estimate -0.06
  • Low Estimate -0.70
  • Prior Year -0.50
  • Growth Rate Est. (year over year) +30.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
40.12 +9.25%
on 04/07/25
Period Open: 47.06
47.52 -7.77%
on 03/10/25
-3.23 (-6.86%)
since 03/07/25
3-Month
40.12 +9.25%
on 04/07/25
Period Open: 57.10
60.88 -28.01%
on 01/13/25
-13.27 (-23.24%)
since 01/07/25
52-Week
40.12 +9.25%
on 04/07/25
Period Open: 70.23
74.44 -41.12%
on 04/09/24
-26.40 (-37.59%)
since 04/05/24

Most Recent Stories

More News
Immuno-Oncology Stocks Q4 Highlights: Incyte (NASDAQ:INCY)

Immuno-Oncology Stocks Q4 Highlights: Incyte (NASDAQ:INCY)

NTRA : 138.26 (+3.28%)
EXAS : 43.83 (+3.01%)
INCY : 60.29 (-0.48%)
REGN : 572.78 (-0.12%)
2 Small-Cap Stocks on Our Watchlist and 1 to Ignore

2 Small-Cap Stocks on Our Watchlist and 1 to Ignore

FVRR : 23.41 (+5.45%)
TENB : 31.88 (-0.53%)
EXAS : 43.83 (+3.01%)
1 Healthcare Stock on Our Watchlist and 2 to Turn Down

1 Healthcare Stock on Our Watchlist and 2 to Turn Down

GH : 41.78 (+2.96%)
EXAS : 43.83 (+3.01%)
EVH : 9.40 (-5.91%)
Natera (NASDAQ:NTRA) Q4 Earnings: Leading The Immuno-Oncology Pack

Natera (NASDAQ:NTRA) Q4 Earnings: Leading The Immuno-Oncology Pack

NTRA : 138.26 (+3.28%)
EXAS : 43.83 (+3.01%)
INCY : 60.29 (-0.48%)
REGN : 572.78 (-0.12%)
1 Stock Under $50 to Target This Week and 2 to Turn Down

1 Stock Under $50 to Target This Week and 2 to Turn Down

SHOO : 22.26 (-7.63%)
EXAS : 43.83 (+3.01%)
IAC : 34.53 (-2.65%)
ReShape Lifesciences, Allarity, Exact Sciences, CVS, AbbVie: 5 Health Care Stocks That Led Retail Message Growth Last Week

Speculation over an impending reverse merger, a Phase 2 trial announcement, comments about upcoming cancer screening tests, a Medicare business deal, and an obesity drug partnership sparked buzz among...

CVS : 63.85 (+0.30%)
EXAS : 43.83 (+3.01%)
ABBV : 186.55 (-0.22%)
RSLS : 0.4333 (-5.80%)
ALLR : 0.8000 (+1.13%)
Natera (NTRA) Q4 Earnings: What To Expect

Natera (NTRA) Q4 Earnings: What To Expect

NTRA : 138.26 (+3.28%)
EXAS : 43.83 (+3.01%)
REGN : 572.78 (-0.12%)
2 Stocks Down 59% and 34% to Buy and Hold

Warren Buffett, arguably the greatest investor of all time, once said it is wise for investors to be fearful when others are greedy. One way to apply this advice from the Oracle of Omaha is to look at...

GH : 41.78 (+2.96%)
ETSY : 43.64 (-1.76%)
EXAS : 43.83 (+3.01%)
ORCL : 127.16 (-0.87%)
Why Exact Sciences (EXAS) Shares Are Trading Lower Today

Why Exact Sciences (EXAS) Shares Are Trading Lower Today

EXAS : 43.83 (+3.01%)
Exact Sciences (EXAS) Q4 2024 Earnings Call Transcript

EXAS earnings call for the period ending December 31, 2024.

EXAS : 43.83 (+3.01%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Exact Sciences Corporation is a molecular diagnostics company focused on the early detection and prevention of some of the deadliest forms of cancer. The company has developed an accurate, non-invasive, patient-friendly screening test called Cologuard for the early detection of colorectal cancer and...

See More

Key Turning Points

3rd Resistance Point 53.19
2nd Resistance Point 49.84
1st Resistance Point 46.83
Last Price 43.83
1st Support Level 40.47
2nd Support Level 37.12
3rd Support Level 34.11

See More

52-Week High 74.44
Fibonacci 61.8% 61.33
Fibonacci 50% 57.28
Fibonacci 38.2% 53.23
Last Price 43.83
52-Week Low 40.12

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trader's Cheat Sheet: Your Secret Weapon for Smarter Trades